SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-033801
Filing Date
2024-02-13
Accepted
2024-02-13 16:30:34
Documents
14
Period of Report
2024-02-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d785029d8k.htm   iXBRL 8-K 26061
  Complete submission text file 0001193125-24-033801.txt   147752

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240208.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240208_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240208_pre.xml EX-101.PRE 11252
16 EXTRACTED XBRL INSTANCE DOCUMENT d785029d8k_htm.xml XML 3663
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 24626570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)